TRINITY MUSCATINE — History
CCN 160013 | 3-year financial timeline | COVID resilience: 58/100
🛡️ Public data only — no PHI permitted on this instance.
$54M
Latest Revenue (FY2022)
+7.0%
Revenue CAGR (3yr)
0.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $47M | $56M | $54M | -2.6% | +7.0% |
| Operating Expenses | $51M | $55M | $54M | -1.3% | +2.4% |
| Operating Margin | -8.9% | 1.6% | 0.3% | -83.2% | +0.0% |
| Net Income | $-4M | $1M | $0M | -83.6% | +0.0% |
| Licensed Beds | 29 | 13 | 18 | +38.5% | -21.2% |
| Total Patient Days | 2,463 | 2,744 | 2,674 | -2.6% | +4.2% |
| Medicare Day % | 37% | 43% | 40% | -6.1% | +3.7% |
| Medicaid Day % | 7% | 1% | 4% | +268.7% | -27.3% |
COVID Impact & Recovery
Resilience Score: 58/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +14.4% ($47M → $54M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+7.0%
This Hospital
+7.6%
State Avg
Latest Margin
0.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $57M | 4.8% |
| FY2024 (proj) | $61M | 9.4% |
| FY2025 (proj) | $64M | 14.0% |